Consensus-built recommendations to improve prostate cancer outcomes: A summary of the American Cancer Society Prostate Cancer Collaborative

  • 0American Cancer Society, Atlanta, Georgia, USA.

|

|

Summary

This summary is machine-generated.

Prostate cancer incidence is rising, reversing progress. A new American Cancer Society plan aims to improve screening, treatment, and management of advanced prostate cancer to reduce mortality.

Area Of Science

  • Oncology
  • Public Health
  • Cancer Research

Background

  • Prostate cancer incidence in the US has increased since 2014, reversing prior declines.
  • Mortality rates have plateaued despite advances in screening (PSA testing) and therapeutics.
  • Urgent multidisciplinary action is needed to prevent increased loss of life and economic burden.

Purpose Of The Study

  • To identify barriers and opportunities for innovation in prostate cancer management.
  • To develop a strategic action plan to address rising prostate cancer incidence and plateaued mortality.
  • To foster collaboration across the prostate cancer continuum.

Main Methods

  • Convened a collaborative of experts across the prostate cancer continuum.
  • Conducted consensus-building exercises to identify strategic priorities.
  • Developed an action plan focused on risk assessment, screening, localized treatment, and advanced disease management.

Main Results

  • Identified three strategic priorities for improving prostate cancer outcomes.
  • Launched the ACS National Prostate Cancer Roundtable to coordinate efforts.
  • Established a framework for improving risk assessment, screening uptake, and therapeutic interventions.

Conclusions

  • A coordinated, multidisciplinary approach is essential to reverse current negative trends in prostate cancer.
  • The ACS National Prostate Cancer Roundtable will drive progress toward improving prostate cancer outcomes.
  • Strategic priorities focus on early detection, optimized treatment, and effective management of advanced disease.

Related Concept Videos

Cancer Survival Analysis 01:21

455

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

Acute Coronary Syndrome IV:  Interprofessional Care 01:28

27

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...

Cancer Prevention 02:59

6.3K

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...

mTOR Signaling and Cancer Progression 03:03

3.9K

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Cancer-Critical Genes II: Tumor Suppressor Genes 01:05

8.0K

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

Combination Therapies and Personalized Medicine 02:50

5.1K

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...